Open Access Policy

Open Access Policy

The Journal of Intelligent Drug Discovery and Genomic Medicine (IJIDDGM) is a fully open-access journal. All published articles are made freely and immediately available online without subscription or access barriers.

1. Immediate Open Access

IJIDDGM provides immediate open access to its published content. No embargo period is applied to articles published by the journal.

2. Copyright

Authors retain copyright in their work and grant IJIDDGM and Prime Crest Publishers the right of first publication.

3. Creative Commons Licence

Articles published by IJIDDGM are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0).

Under this licence, users may share, copy, redistribute, adapt and build upon published material for any purpose, provided that appropriate credit is given to the original author(s) and source, a link to the licence is provided, and any changes made are indicated.

4. Author Sharing and Archiving

Authors may share and distribute their published articles and may deposit the published version in institutional repositories, subject repositories, personal or institutional websites and other appropriate scholarly platforms, provided that the original publication in IJIDDGM is appropriately acknowledged.

5. Reader Access

Readers may access, read and use published IJIDDGM articles without registration, subscription or payment, subject to the terms of the applicable Creative Commons licence.

6. Open Knowledge

IJIDDGM supports open scholarly communication and the broad dissemination of research in drug discovery, genomic medicine, computational biology, pharmaceutical sciences, artificial intelligence, bioinformatics and precision medicine.